NIFTY  9,360.55  -0.27%
  SENSEX  30,301.60  -0.21%
 CURRENCY  Rs  64.89/$ 72.59/€, 84.18/£
  GOLD  28,710.00  -0.35%
  SILVER  39,830.00  -0.32%
  DAX  12,642.90  -0.13%
  FTSE  7,514.90  0.40%
  CAC  5,341.34  -0.11%
  HANG SENG  25,428.50  0.10%
  NIKKEI  19,743.00  0.66%
  Shanghai Composite  3,064.08  0.03%
  DOW JONES  21,012.40  0.36%
  NASDAQ  6,163.02  0.40%
  S&P 500  2,404.39  0.25%
SOURCES TO COGENCIES : Cabinet Approves Proposal For Abolition Of Foreign Investment Promotion Board SOURCES TO COGENCIES : Cabinet Approves Proposal On 2017-18 Sugarcane Prices SOURCES TO COGENCIES : Need For Cabinet Nod For FDI Over Rs 5000 Cr To Remain TATA INVEST Q4 EARNINGS : PAT Rs 16.1 Cr Vs Rs 22.3 Cr YoY TATA INVEST Q4 EARNINGS : Revenue Rs 35.8 Cr Vs Rs 32.3 Cr YoY TATA INVEST Q4 EARNINGS : To Pay Dividend Of Rs 18/Share PRASUN GAJRI HDFC LIFE : I.T. Stocks May Perform Better On A Short-Term Basis FROM REUTERS : KOC & Tata Group Sign Joint Venture To Tap Into White Goods Consumer Market

“Indian Regulator Eager To Work With U.S. FDA”

Video:

Play this video

February 19: “The Drug Controller General of India (DCGI) has welcomed the opportunity to observe our inspections,” says, Margaret Hamburg, Commissioner, U.S. FDA. Further, she adds, “It is important that Indian regulators engage in international forums.”